drugset / Trial / NCT01366365
Study of Pharmacokinetics, Safety and Tolerability of Intravenous Methylnaltrexone Bromide
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This double-blind, randomized, two-cohort, placebo-controlled, parallel group study characterized the pharmacokinetics, safety, and tolerability of MNTX following single doses and at steady-state during multiple dosing and assessed the effects of aging on the pharmacokinetics, safety and tolerability of MNTX.
Timeline
- Start
- 2006-10
- Primary completion
- 2006-11
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylnaltrexone | Other / unclassified | — | Intravenous |
Indications
No indication recorded.